MAPT and Alzheimer disease: The decreased Aβ42/Aβ40 ratio in CSF (Miao et al., 2022) and increased p-tau181 levels (Ghahremani et al., 2023b) suggest that MBI may be associated with the amyloid cascade and tau phosphorylation in Alzheimer’s disease.